KIF2C accelerates the development of non-small cell lung cancer and is suppressed by miR-186-3p via the AKT-GSK3β-β-catenin pathway

[1]  Zhiyong Zhang,et al.  Hsa-miR-186-3p suppresses colon cancer progression by inhibiting KRT18/MAPK signaling pathway , 2022, Cell cycle.

[2]  Juan Wang,et al.  MiR-186 Suppressed Growth, Migration, and Invasion of Lung Adenocarcinoma Cells via Targeting Dicer1 , 2021, Journal of Oncology.

[3]  C. Solbach,et al.  Mitotic Centromere-Associated Kinesin (MCAK/KIF2C) Regulates Cell Migration and Invasion by Modulating Microtubule Dynamics and Focal Adhesion Turnover , 2021, Cancers.

[4]  H. Konishi,et al.  Tumor-Progressive Mechanisms Mediating miRNA–Protein Interaction , 2021, International journal of molecular sciences.

[5]  Nan Jiang,et al.  Activation of the TGF-β1/Smad signaling by KIF2C contributes to the malignant phenotype of thyroid carcinoma cells. , 2021, Tissue & cell.

[6]  R. Rintoul,et al.  Adenocarcinoma spectrum lesions of the lung: Detection, pathology and treatment strategies. , 2021, Cancer treatment reviews.

[7]  F. Baltazar,et al.  Cancer Cells’ Metabolism Dynamics in Renal Cell Carcinoma Patients’ Outcome: Influence of GLUT-1-Related hsa-miR-144 and hsa-miR-186 , 2021, Cancers.

[8]  H. Kajiyama,et al.  ChrXq27.3 miRNA cluster functions in cancer development , 2021, Journal of experimental & clinical cancer research : CR.

[9]  Haiwang Liu,et al.  Kinesin family member 3C (KIF3C) is a novel non-small cell lung cancer (NSCLC) oncogene whose expression is modulated by microRNA-150-5p (miR-150-5p) and microRNA-186-3p (miR-186-3p) , 2021, Bioengineered.

[10]  Xiaoyu Liu,et al.  miR-186-3p attenuates the tumorigenesis of cervical cancer via targeting insulin-like growth factor 1 to suppress PI3K-Akt signaling pathway , 2021, Bioengineered.

[11]  M. Brizzi,et al.  The Wnt Signalling Pathway: A Tailored Target in Cancer , 2020, International journal of molecular sciences.

[12]  H. Zeng,et al.  Stemness Related Genes Revealed by Network Analysis Associated With Tumor Immune Microenvironment and the Clinical Outcome in Lung Adenocarcinoma , 2020, Frontiers in Genetics.

[13]  T. Kang,et al.  KIF2C: a novel link between Wnt/β-catenin and mTORC1 signaling in the pathogenesis of hepatocellular carcinoma , 2020, Protein & Cell.

[14]  Binbin Lu,et al.  Up-regulated LINC01234 promotes non-small-cell lung cancer cell metastasis by activating VAV3 and repressing BTG2 expression , 2020, Journal of Hematology & Oncology.

[15]  D. Virshup,et al.  Wnt Signaling and Drug Resistance in Cancer , 2019, Molecular Pharmacology.

[16]  Yufei Gao,et al.  KIF2C exerts an oncogenic role in nonsmall cell lung cancer and is negatively regulated by miR‐325‐3p , 2019, Cell biochemistry and function.

[17]  G. Eapen,et al.  Lung Cancer. , 2019, The Medical clinics of North America.

[18]  Wei Zhu,et al.  The miR-186-3p/EREG axis orchestrates tamoxifen resistance and aerobic glycolysis in breast cancer cells , 2019, Oncogene.

[19]  Roy S. Herbst,et al.  The biology and management of non-small cell lung cancer , 2018, Nature.

[20]  Zheng Wang,et al.  MiR-186 inhibits proliferation, migration, and invasion of non-small cell lung cancer cells by downregulating Yin Yang 1. , 2017, Cancer biomarkers : section A of Disease markers.

[21]  Musaddique Hussain,et al.  Wnt/β-catenin signaling links embryonic lung development and asthmatic airway remodeling. , 2017, Biochimica et biophysica acta. Molecular basis of disease.

[22]  W. Choi,et al.  Interstitial Lung Disease and Lung Cancer Development: A 5-Year Nationwide Population-Based Study , 2017, Cancer research and treatment : official journal of Korean Cancer Association.

[23]  Walter J Curran,et al.  Lung cancer: current therapies and new targeted treatments , 2017, The Lancet.

[24]  Jianxing He,et al.  MicroRNA-186 suppresses cell proliferation and metastasis through targeting MAP3K2 in non-small cell lung cancer. , 2016, International journal of oncology.

[25]  J. Minna,et al.  Lung cancer cell lines: Useless artifacts or invaluable tools for medical science? , 2010, Lung cancer.

[26]  Anindya Dutta,et al.  MicroRNAs in cancer. , 2009, Annual review of pathology.

[27]  N. Harbeck,et al.  Efficacy of deescalated chemotherapy according to PAM50 subtypes, immune and proliferation genes in triple‐negative early breast cancer: Primary translational analysis of the WSG‐ADAPT‐TN trial , 2019, International journal of cancer.

[28]  R. Kurzrock,et al.  Targeting the Wnt/beta-catenin pathway in cancer: Update on effectors and inhibitors. , 2018, Cancer treatment reviews.